DE60207514D1 - Zusammensetzungen und Verfahren zum Nachweis und zur Behandlung von mit Chemokinrezeptoren verbundenen Krankheiten - Google Patents
Zusammensetzungen und Verfahren zum Nachweis und zur Behandlung von mit Chemokinrezeptoren verbundenen KrankheitenInfo
- Publication number
- DE60207514D1 DE60207514D1 DE60207514T DE60207514T DE60207514D1 DE 60207514 D1 DE60207514 D1 DE 60207514D1 DE 60207514 T DE60207514 T DE 60207514T DE 60207514 T DE60207514 T DE 60207514T DE 60207514 D1 DE60207514 D1 DE 60207514D1
- Authority
- DE
- Germany
- Prior art keywords
- topology
- detecting
- compositions
- methods
- diseases associated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57411—Specifically defined cancers of cervix
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57415—Specifically defined cancers of breast
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57449—Specifically defined cancers of ovaries
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/10—Screening for compounds of potential therapeutic value involving cells
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US33810001P | 2001-11-30 | 2001-11-30 | |
US338100P | 2001-11-30 | ||
US245850 | 2002-09-16 | ||
US10/245,850 US7442512B2 (en) | 2001-11-30 | 2002-09-16 | Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60207514D1 true DE60207514D1 (de) | 2005-12-29 |
DE60207514T2 DE60207514T2 (de) | 2006-08-10 |
Family
ID=26937511
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60207514T Expired - Lifetime DE60207514T2 (de) | 2001-11-30 | 2002-09-30 | Zusammensetzungen und Verfahren zum Nachweis und zur Behandlung von mit Chemokinrezeptoren verbundenen Krankheiten |
Country Status (10)
Country | Link |
---|---|
US (1) | US7442512B2 (de) |
EP (2) | EP1316801B1 (de) |
JP (1) | JP4485204B2 (de) |
KR (1) | KR100961237B1 (de) |
AT (1) | ATE310955T1 (de) |
AU (1) | AU2002351213B2 (de) |
CA (1) | CA2468407A1 (de) |
DE (1) | DE60207514T2 (de) |
DK (1) | DK1316801T3 (de) |
WO (1) | WO2003047420A2 (de) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7871619B2 (en) * | 2001-11-30 | 2011-01-18 | Chemocentryx, Inc. | Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors |
EP1365245A1 (de) * | 2002-05-23 | 2003-11-26 | Bayer Aktiengesellschaft | Diagnostika und Therapeutika von mit Chemokine Rezeptor 11 (CCR11) assoziierten Krankheiten |
US7964194B2 (en) * | 2002-11-15 | 2011-06-21 | Morehouse School Of Medicine | Anti-chemokine and associated receptor antibodies and uses for inhibition of inflammation |
PT1691837E (pt) * | 2003-12-10 | 2012-08-27 | Medarex Inc | Anticorpos ip-10 e suas utilizações |
JP4452839B2 (ja) * | 2004-03-09 | 2010-04-21 | 国立大学法人京都大学 | Cxcr3阻害剤を含有する医薬組成物 |
CN100357738C (zh) * | 2004-03-26 | 2007-12-26 | 博奥生物有限公司 | 一种检测小分子化合物的方法 |
CA2501422C (en) * | 2004-04-29 | 2014-08-12 | University Of Rochester | Lymphoid chemokines in the diagnosis, monitoring and treatment of autoimmune disease |
US20100143899A1 (en) * | 2005-05-17 | 2010-06-10 | University Of Vermont And State Agricultural College | Methods and products for diagnosing cancer |
DE602006008310D1 (de) * | 2005-06-22 | 2009-09-17 | Univ Johns Hopkins | Biomarker für eierstockkrebs: mit ctap3 verwandte proteine |
CA2646902C (en) | 2006-04-21 | 2017-01-31 | Centocor Inc. | Cxcl13 antagonists and their use for the treatment of inflammatory diseases |
GB0614755D0 (en) | 2006-07-25 | 2006-09-06 | Univ Geneve | Cytokine derivatives |
PT2486941T (pt) * | 2006-10-02 | 2017-05-30 | Squibb & Sons Llc | Anticorpos humanos que ligam a cxcr4 e utilizações dos mesmos |
US9512236B2 (en) | 2006-12-19 | 2016-12-06 | Ablynx N.V. | Amino acid sequences directed against GPCRS and polypeptides comprising the same for the treatment of GPCR-related diseases and disorders |
WO2008134020A1 (en) * | 2007-04-26 | 2008-11-06 | University Of Vermont And State Agricultural College | Ccl18 and ccl3 methods and compositions for detecting and treating cancer |
JP5555626B2 (ja) * | 2007-08-13 | 2014-07-23 | バクスター・インターナショナル・インコーポレイテッド | 多発性硬化症、アルツハイマー病およびパーキンソン病を処置するためのケモカインのivig調節 |
EP2182976A4 (de) * | 2007-08-31 | 2012-01-25 | Massachusetts Inst Technology | Behandlung von autoimmunerkrankungen |
BRPI0911984A2 (pt) * | 2008-05-16 | 2016-09-20 | Ablynx Nv | sequências de aminoácidos direncionadas contra cxcr4 e outros compostos gpcrs compreendendo os mesmos |
US8937164B2 (en) | 2010-03-26 | 2015-01-20 | Ablynx N.V. | Biological materials related to CXCR7 |
CN103347896B (zh) | 2010-09-02 | 2017-06-13 | 瓦西尼斯公司 | 抗cxcl13抗体和其使用方法 |
ES2723775T3 (es) * | 2010-11-08 | 2019-09-02 | Ablynx Nv | Polipéptidos que se unen a CXCR2 |
AR084141A1 (es) | 2010-11-19 | 2013-04-24 | Imai Toshio | Anticuerpos neutralizadores anti-ccl20 |
US20150158948A9 (en) | 2011-03-28 | 2015-06-11 | Francis Descamps | Bispecific anti-cxcr7 immunoglobulin single variable domains |
KR101359317B1 (ko) * | 2011-08-23 | 2014-02-10 | 건양대학교산학협력단 | D6 디코이 수용체의 세포 외 도메인 1을 포함하는 항암용 약학 조성물 |
JP6193275B2 (ja) | 2012-03-02 | 2017-09-06 | ヴァクシネックス, インコーポレイテッド | B細胞媒介炎症性疾患を治療するための方法 |
EP2682187B1 (de) * | 2012-07-02 | 2017-09-13 | Molecular Devices, LLC | Auswahlverfahren und -vorrichtung |
CN104884087B (zh) | 2012-09-06 | 2019-07-30 | 阿德莱德研究创新有限公司 | 预防和/或治疗转移性癌症的产品和方法 |
AU2014212206B2 (en) | 2013-01-31 | 2018-10-18 | Vaccinex, Inc. | Methods for increasing immunoglobulin A levels |
CA2988086C (en) | 2015-06-03 | 2023-09-19 | The Medical College Of Wisconsin, Inc. | An engineered ccl20 locked dimer polypeptide |
US11571462B2 (en) | 2015-06-03 | 2023-02-07 | The Medical College Of Wisconsin, Inc. | Engineered CCL20 locked dimer polypeptide |
EP3314255B1 (de) | 2015-06-25 | 2019-07-31 | H. Hoffnabb-La Roche Ag | Zellbasierter assay zur bestimmung von antikörpern oder ligandenbindung und funktion |
AU2017330741A1 (en) | 2016-09-26 | 2019-05-02 | Mpo, Inc. | Egg, fertilized egg, or embryo quality improving agent |
JOP20190187A1 (ar) | 2017-02-03 | 2019-08-01 | Novartis Ag | مترافقات عقار جسم مضاد لـ ccr7 |
CN107312092B (zh) * | 2017-05-04 | 2020-12-11 | 华南农业大学 | 一种斜带石斑鱼ccr12的多克隆抗体制备方法及其应用 |
CN113684238A (zh) * | 2021-08-09 | 2021-11-23 | 广州医科大学附属第一医院(广州呼吸中心) | Cxc趋化因子受体3作为咳嗽药物靶点的用途 |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4166452A (en) * | 1976-05-03 | 1979-09-04 | Generales Constantine D J Jr | Apparatus for testing human responses to stimuli |
US4256108A (en) * | 1977-04-07 | 1981-03-17 | Alza Corporation | Microporous-semipermeable laminated osmotic system |
US4265874A (en) * | 1980-04-25 | 1981-05-05 | Alza Corporation | Method of delivering drug with aid of effervescent activity generated in environment of use |
US4927838A (en) * | 1987-07-10 | 1990-05-22 | Hoffman-La Roche Inc. | Pyridine compounds which are useful in treating a disease state characterized by an excess of platelet activating factors |
US6537764B1 (en) | 1995-01-19 | 2003-03-25 | Children's Medical Center Corporation | Method of identifying inhibitors of C—C chemokine receptor 3 |
SE9600820D0 (sv) * | 1996-03-01 | 1996-03-01 | Pharmacia Ab | Antibodies and their use |
GB9712818D0 (en) * | 1996-07-08 | 1997-08-20 | Cambridge Antibody Tech | Labelling and selection of specific binding molecules |
US6140064A (en) * | 1996-09-10 | 2000-10-31 | Theodor-Kocher Institute | Method of detecting or identifying ligands, inhibitors or promoters of CXC chemokine receptor 3 |
JP4502408B2 (ja) | 1996-09-10 | 2010-07-14 | テオドーア−コッヒャー インスティトゥーテ | Cxcr3ケモカイン受容体、抗体、核酸および使用方法 |
US5876946A (en) * | 1997-06-03 | 1999-03-02 | Pharmacopeia, Inc. | High-throughput assay |
EP0897980A3 (de) | 1997-08-20 | 2002-04-17 | Smithkline Beecham Corporation | CXCR4B: Eine menschliche Spleissvariante des CXCR4 Chemokinrezeptors |
US6306653B1 (en) * | 1998-01-20 | 2001-10-23 | Codon Diagnostics, Llc | Detection and treatment of breast disease |
ATE525477T1 (de) | 1998-03-30 | 2011-10-15 | Northwest Biotherapeutics Inc | Therapeutische und diagnostische anwendungen welche auf der rolle von cxcr-4 in der tumorgenese basieren |
US6287765B1 (en) * | 1998-05-20 | 2001-09-11 | Molecular Machines, Inc. | Methods for detecting and identifying single molecules |
US6449054B1 (en) * | 1998-08-01 | 2002-09-10 | Canon Kabushiki Kaisha | Dynamic assignment of group addresses for controlling parallel peripheral devices |
US6329510B1 (en) * | 1999-01-29 | 2001-12-11 | Millennium Pharmaceuticals, Inc. | Anti-CCR1 antibodies and methods of use therefor |
US6329159B1 (en) * | 1999-03-11 | 2001-12-11 | Millennium Pharmaceuticals, Inc. | Anti-GPR-9-6 antibodies and methods of identifying agents which modulate GPR-9-6 function |
US6365356B1 (en) * | 1999-03-17 | 2002-04-02 | Cornell Research Foundation, Inc. | Receptors that regulate cell signaling relating to chemokines |
CA2367173A1 (en) * | 1999-04-08 | 2000-10-12 | The General Hospital Corporation | Purposeful movement of human migratory cells away from an agent source |
US20020061599A1 (en) * | 1999-12-30 | 2002-05-23 | Elling Christian E. | Method of identifying ligands of biological target molecules |
MXPA02007730A (es) * | 2000-02-09 | 2002-10-11 | Human Genome Sciences Inc | Receptor de quimiocina de proteina g humana (ccr5) hdgnr10. |
US20020064770A1 (en) * | 2000-03-21 | 2002-05-30 | Nestor John J. | Binding compounds and methods for identifying binding compounds |
AU2001271502A1 (en) * | 2000-06-26 | 2002-01-08 | Gpc Biotech Ag | Methods and compositions for isolating biologically active antibodies |
-
2002
- 2002-09-16 US US10/245,850 patent/US7442512B2/en active Active
- 2002-09-30 EP EP02256808A patent/EP1316801B1/de not_active Expired - Lifetime
- 2002-09-30 DE DE60207514T patent/DE60207514T2/de not_active Expired - Lifetime
- 2002-09-30 AT AT02256808T patent/ATE310955T1/de not_active IP Right Cessation
- 2002-09-30 DK DK02256808T patent/DK1316801T3/da active
- 2002-12-02 CA CA002468407A patent/CA2468407A1/en not_active Abandoned
- 2002-12-02 AU AU2002351213A patent/AU2002351213B2/en not_active Ceased
- 2002-12-02 JP JP2003548686A patent/JP4485204B2/ja not_active Expired - Lifetime
- 2002-12-02 WO PCT/US2002/038555 patent/WO2003047420A2/en not_active Application Discontinuation
- 2002-12-02 EP EP02786859A patent/EP1461061A4/de not_active Withdrawn
- 2002-12-02 KR KR1020047008339A patent/KR100961237B1/ko active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
JP2005527189A (ja) | 2005-09-15 |
DE60207514T2 (de) | 2006-08-10 |
ATE310955T1 (de) | 2005-12-15 |
WO2003047420A3 (en) | 2004-02-26 |
US20030124628A1 (en) | 2003-07-03 |
KR100961237B1 (ko) | 2010-06-03 |
AU2002351213B8 (en) | 2003-06-17 |
EP1316801A1 (de) | 2003-06-04 |
DK1316801T3 (da) | 2006-03-06 |
AU2002351213B2 (en) | 2008-01-03 |
CA2468407A1 (en) | 2003-06-12 |
KR20040099258A (ko) | 2004-11-26 |
AU2002351213A1 (en) | 2003-06-17 |
US7442512B2 (en) | 2008-10-28 |
EP1461061A4 (de) | 2005-08-31 |
JP4485204B2 (ja) | 2010-06-16 |
EP1316801B1 (de) | 2005-11-23 |
WO2003047420A2 (en) | 2003-06-12 |
EP1461061A2 (de) | 2004-09-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60207514D1 (de) | Zusammensetzungen und Verfahren zum Nachweis und zur Behandlung von mit Chemokinrezeptoren verbundenen Krankheiten | |
ATE526041T1 (de) | Verfahren zur hemmung okularer vorgänge | |
TR200100267T2 (tr) | İkameli anilid bileşimleri ve yöntemler. | |
ATE499392T1 (de) | Polyolefin mit verbesserter kratzfestigkeit und verfahren zu seiner herstelung | |
ATE502648T1 (de) | Verfahren zur behandlung von autoimmunerkrankungen bei einem probanden und diagnostische in-vitro-assays | |
CY1111863T1 (el) | Αντισωματα εναντιον υποδοχεα θανατου 4 (dr4) και χρησεις αυτων | |
ATE424560T1 (de) | Marker für neuromyelitis optica | |
EP2101772A4 (de) | Neuromuskuläre blocker mit mittlerer dauer und antagonisten advon | |
ATE429450T1 (de) | Chimärische dr4 antikörper und ihre verwendung | |
DE60126337D1 (de) | Verfahren zum screenen für gpr40-liganden | |
DE602004016499D1 (de) | Zusammensetzungen und verfahren zur behandlung von entzündlicher darmerkrankung | |
PT1560812E (pt) | Compostos de aminociclohexil eter e suas utilizacoes | |
WO2004108887A3 (en) | Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors | |
ATE504833T1 (de) | Verfahren zur bestimmung des phänotyps von zellen | |
CO5460266A1 (es) | Novedosos analogos de la somatostatina | |
BR0014150A (pt) | Diagnósticos e terapêuticos para osteoporose | |
DE602004029061D1 (de) | Zusammensetzungen, reagenzien, kits und verfahren für die diagnose und behandlung von fettleibigkeit und/oder diabetes | |
DE602006019733D1 (de) | Verfahren und zusammensetzungen zur notfallbedingten verhütung mithilfe von endothelin-rezeptor-antagonisten | |
DE60033576D1 (de) | Methoden zum screening knochenmorphogenetishemimetika | |
DE50007635D1 (de) | Verfahren zur diagnose von sjögren-syndrom | |
ATE432996T1 (de) | Verfahren zur bestimmung des bodenzustands | |
ATE253223T1 (de) | Verfahren und materialien zur diagnose instabiler angina | |
ATE447586T1 (de) | Fprl1-liganden und deren verwendung | |
ATE440993T1 (de) | Mit calixarenen ausgerüstete textile materialien, verfahren zu ihrer herstellung und ihre verwendung | |
SG170009A1 (en) | Polypeptide markers for the diagnosis and evaluation of vascular diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |